schizandrer a has been researched along with lignans in 63 studies
Studies (schizandrer a) | Trials (schizandrer a) | Recent Studies (post-2010) (schizandrer a) | Studies (lignans) | Trials (lignans) | Recent Studies (post-2010) (lignans) |
---|---|---|---|---|---|
65 | 0 | 52 | 7,024 | 95 | 4,172 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (4.76) | 18.7374 |
1990's | 1 (1.59) | 18.2507 |
2000's | 6 (9.52) | 29.6817 |
2010's | 44 (69.84) | 24.3611 |
2020's | 9 (14.29) | 2.80 |
Authors | Studies |
---|---|
Ikeya, Y; Kobayashi, H; Taguchi, H; Yosioka, I | 1 |
Lesca, P; Liu, KT | 2 |
Chen, CC; Hsu, MF; Raung, SL; Wang, JP | 1 |
Hiratsuka, A; Iwata, H; Kadota, S; Tezuka, Y; Watabe, T | 1 |
Hu, X; Lu, Q; Pan, Q; Zhang, K | 1 |
Chang, YJ; Choi, G; Choi, YB; Do, EU; Kang, TM; Kim, HJ; Kim, SI; Nam, HY; Piao, LZ; Shin, J | 1 |
Huang, X; Liu, SY; Liu, ZQ; Song, FR | 1 |
Gao, XM; He, F; Huang, SX; Lu, Y; Pu, JX; Sun, HD; Wang, RR; Xiao, WL; Zheng, QT; Zheng, YT; Zhong, JL | 1 |
Chen, M; Li, L; Xu, XM | 1 |
Chen, W; Gao, S; Sun, L; Tai, Z; Wei, H; Xu, W | 1 |
Ci, X; Deng, X; Li, H; Li, R; Ren, R; Song, Y; Wang, D; Xu, K; Yu, Q | 1 |
Lin, X; Shaw, PC; Song, JX; Sze, SC; Tong, Y; Wong, RN; Zhang, YB | 1 |
Chai, X; Chen, S; Yu, C; Yu, L; Zeng, S | 1 |
Guan, M; Li, T; Liu, Y; Sheng, Y; Wang, Y; Yuan, G | 1 |
Liu, TT; Ma, CH; Yang, FJ; Yang, L; Zhang, L; Zhang, ZH; Zhao, CJ; Zu, YG | 1 |
Li, D; Li, R; Ye, Z; Zhang, Q; Zhou, D | 1 |
Choi, YW; Kang, JS; Kim, SG; Kim, YH; Lee, SJ; Park, DJ; Park, SY; Ryu, EY; Seetharaman, R | 1 |
Xiao, Y; Zhang, H | 1 |
Dong, JP; He, FC; Li, SX; Liu, WZ; Su, RQ; Zhao, ZQ | 1 |
Han, Y; Sun, H; Wang, X; Wei, W; Wu, F; Zhang, A | 1 |
Cao, YF; Fan, XR; Fang, ZZ; Hu, CM; Huang, T; Liu, C; Mo, H; Sun, XY; Zeng, J; Zhang, YY | 1 |
Bi, K; Chen, X; Fan, R; Geng, L; He, B; Jia, Y; Li, Q; Su, D; Wei, B; Zhao, L | 1 |
Chang, R; Dou, L; Li, X; Li, Y; Wang, Y; Yang, X; Yue, Y; Zhang, W | 1 |
Bi, HC; Chen, X; Huang, M; Li, JL; Qin, XL; Wang, CX; Wang, XD; Wang, Y; Xue, XP; Yang, H; Zhong, GP | 1 |
Bae, YS; Choi, YW; Ko, MJ; Lee, SJ; Park, SY | 1 |
Hu, XL; Liu, ZQ; Pi, ZF; Song, FR; Yu, XL | 1 |
Bi, K; Guo, L; Jia, Y; Li, H; Li, X; Liu, Z; Mao, X; Xu, X; Zhao, X | 1 |
Chen, X; He, Y; Peng, D; Shen, Y; Zhang, Q; Zhou, F | 1 |
Fu, Y; Lei, H; Li, Y; Wei, Z; Xie, G; Yang, Z; Zhang, N; Zhou, E | 1 |
Ci, X; Jie, J; Li, D; Li, Y; Liu, C; Peng, L; Wen, Z | 1 |
Bi, H; Chen, P; Fan, X; Huang, M; Jiang, Y; Tan, H; Wang, Y; Zeng, H | 1 |
Chong, CM; Guo, BJ; Hoi, PM; Lee, SM; Li, S; Sa, F; Zhang, LQ; Zhang, ZJ; Zheng, Y | 1 |
Liu, CH; Liu, S; Tao, YY; Yang, T; Zheng, TH | 1 |
An, LP; Chen, M; Dou, ZH; Ju, YF; Luo, L; Miao, YX; Qiao, J | 1 |
Chan, SW; Chang, RC; Chong, CM; Hoi, PM; Sa, F; Wang, Y; Yuen Lee, SM; Zhang, LQ; Zhou, ZY | 1 |
An, LB; Cui, L; Dong, PP; Fang, ZZ; Gonzalez, FJ; Li, WT; Song, JH; Sun, XY; Wang, LX; Wu, X; Zhang, YY; Zhao, DW | 1 |
Chengqing, L; Chenming, N; Tao, L; Xiaoyang, L | 1 |
Jun, F; Li, D; Liao, S; Wang, J; Xie, X; Zhou, K | 1 |
Chen, T; Lee, SM; Li, C; Li, Y; Yi, X; Zheng, Y | 1 |
Chen, T; Lee, SM; Li, C; Li, Y; Wang, R; Yi, X; Zheng, Y | 1 |
Cao, YF; Fang, ZZ; Gonzalez, FJ; Liu, YZ; Sun, HZ; Sun, T; Wu, JJ; Yang, K; Yin, J; Zhao, J; Zhu, ZT | 1 |
Ding, G; Guo, W; Liu, F; Lu, H; Zhan, Y; Zhang, M; Zheng, N | 1 |
Chen, C; Ding, F; Liang, XM; Shi, YW; Tang, M; Wang, CP; Wang, ZW; Zhang, XC | 1 |
Liu, CH; Lv, J; Tao, YY; Zhao, ZM; Zhu, CW | 1 |
Bu, F; Cai, W; Jiao, Z; Li, L; Lin, HS; Ma, G; Shin, JG; Xiang, X; Zhang, H; Zhuang, X | 1 |
Li, B; Li, D; Ma, F; Meng, X; Shi, L; Sun, X; Tian, J; Wang, Y | 1 |
Chen, J; Gao, J; Jing, S; Li, H; Li, N; Liu, C; Sun, J; Sun, W; Wang, C; Yu, C | 1 |
Bi, HC; Chen, X; Duan, WH; Huang, M; Qin, XL; Wang, HF; Wang, Y | 1 |
Feng, YL; Li, W; Liu, KY; Liu, YL; Song, YG; Su, D; Yang, LJ | 1 |
Cheng, X; Ding, XY; Ji, JD; Lu, TL; Mao, CQ; Su, LL; Wang, LJ; Zhang, J | 1 |
Chen, T; Feng, Y; He, C; Hoi, MP; Lee, SM; Li, C; Tang, F; Zhang, C; Zheng, Y; Zhou, H | 1 |
Cao, JQ; Deng, ZW; Du, SS; Geng, ZF; Guo, SS; Liang, JY; Pang, X; Wang, Y | 1 |
Chen, C; Kang, D; Li, H; Li, X; Liang, Y; Shao, Y; Shen, B; Shen, J; Wang, G; Xie, L; Xu, Y; Yin, X; Zhu, Z | 1 |
Chen, L; Fan, J; Li, M; Lu, X; Zhu, L | 1 |
Cao, X; Gao, Z; Hu, T; Hu, Y; Qian, F; Su, F; Wang, Z; Yang, Y; Yu, K | 1 |
Feng, W; Gao, L; Liu, ML; Mu, RF; Niu, LY; Wang, XG; Xu, BY; Zhou, LY | 1 |
Chen, J; Li, H; Lin, C; Sun, J; Wang, C; Xu, Z; Yang, S | 1 |
Ai, X; Dong, J; Han, G; Liu, Y; Song, J; Wang, Z; Yang, Q; Zhong, L | 1 |
Dong, X; Du, X; Hao, X; Lin, L; Ni, J; Qu, C; Wu, H; Xie, L; Yin, X; Zhang, L | 1 |
Gui, Y; Li, J; Tao, S; Xu, D; Yang, Y | 1 |
Che, J; Chen, J; Cui, K; Li, H; Sun, J; Wang, C; Wang, H; Zhuang, W | 1 |
Ding, L; Jiang, J; Li, Q; Liu, X; Wang, Z; Yang, L; Yu, S | 1 |
63 other study(ies) available for schizandrer a and lignans
Article | Year |
---|---|
The constituents of Schizandra chinensis Baill. I. Isolation and structure determination of five new lignans, gomisin A, B, C, F and G, and the absolute structure of schizandrin.
Topics: Chemical Phenomena; Chemistry; Cyclooctanes; Cycloparaffins; Dioxoles; Lignans; Molecular Conformation; Plant Extracts; Plants, Medicinal; Polycyclic Compounds | 1979 |
Pharmacological properties of dibenzo[a,c]cyclooctene derivatives isolated from Fructus Schizandrae chinensis. I. Interaction with rat liver cytochrome P-450 and inhibition of xenobiotic metabolism and mutagenicity.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Cyclooctanes; Cytochrome P-450 Enzyme System; Dioxoles; In Vitro Techniques; Lignans; Male; Medicine, Chinese Traditional; Medicine, East Asian Traditional; Microsomes, Liver; Mutagens; NADP; Oxidation-Reduction; Plants, Medicinal; Polycyclic Compounds; Rats; Rats, Inbred Strains | 1982 |
Pharmacological properties of Dibenzo[a,c]cyclooctene derivatives isolated from Fructus Schizandrae Chinensis III. Inhibitory effects on carbon tetrachloride-induced lipid peroxidation, metabolism and covalent binding of carbon tetrachloride to lipids.
Topics: Animals; Carbon Tetrachloride; China; Cyclooctanes; Dioxoles; Lignans; Lipid Metabolism; Lipid Peroxides; Male; Mice; Mice, Inbred DBA; Microsomes, Liver; NADP; Oxygen Consumption; Plants, Medicinal; Polycyclic Compounds | 1982 |
Inhibition by gomisin C (a lignan from Schizandra chinensis) of the respiratory burst of rat neutrophils.
Topics: Animals; Calcium; Cyclic AMP; Cyclooctanes; Dioxoles; Fumarates; Inositol Phosphates; Lignans; N-Formylmethionine Leucyl-Phenylalanine; NADH, NADPH Oxidoreductases; NADPH Oxidases; Neutrophils; Oxygen Consumption; Plant Extracts; Plants, Medicinal; Rats; Rats, Sprague-Dawley; Respiratory Burst; Superoxides | 1994 |
Identification and characterization of potent CYP3A4 inhibitors in Schisandra fruit extract.
Topics: Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Cyclooctanes; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Dioxoles; Enzyme Inhibitors; Erythromycin; Female; Humans; In Vitro Techniques; Ketoconazole; Lignans; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Microdialysis; Microsomes, Liver; Optical Rotation; Plant Extracts; Polycyclic Compounds; Schisandra; Solvents | 2004 |
Dibenzocyclooctadiene lingnans: a class of novel inhibitors of P-glycoprotein.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Proliferation; Cyclooctanes; Daunorubicin; Dioxoles; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Inhibitory Concentration 50; K562 Cells; Lignans; Paclitaxel; Polycyclic Compounds; Prohibitins; Vincristine | 2006 |
The high throughput screening of neuropeptide FF2 receptor ligands from Korean herbal plant extracts.
Topics: Combinatorial Chemistry Techniques; Cyclooctanes; Dioxoles; Drug Evaluation, Preclinical; Fluorescence Polarization; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Korea; Lignans; Medicine, East Asian Traditional; Peptide Library; Plant Extracts; Receptors, Neuropeptide; Schisandra | 2006 |
[Lignans from different processed products of Schisandra chinensis fruits].
Topics: Chromatography, High Pressure Liquid; Cyclooctanes; Dioxoles; Drug Compounding; Drugs, Chinese Herbal; Fruit; Hot Temperature; Lignans; Plants, Medicinal; Polycyclic Compounds; Quality Control; Schisandra; Spectrometry, Mass, Electrospray Ionization | 2008 |
Nortriterpenoids and lignans from Schisandra sphenanthera.
Topics: Cell Line; Cyclooctanes; Dioxoles; HeLa Cells; HIV-1; Humans; Lignans; Microbial Sensitivity Tests; Plant Extracts; Polycyclic Compounds; Schisandra; Triterpenes | 2008 |
[Studies on the chemical constituents of Schisandra pubescens].
Topics: Chromatography, High Pressure Liquid; Cyclooctanes; Dioxoles; Fruit; Lactones; Lignans; Magnetic Resonance Spectroscopy; Molecular Structure; Plants, Medicinal; Schisandra; Triterpenes | 2009 |
A simple and sensitive HPLC method for the simultaneous determination of eight bioactive components and fingerprint analysis of Schisandra sphenanthera.
Topics: Chromatography, High Pressure Liquid; Cyclooctanes; Dioxoles; Fruit; Lignans; Mass Spectrometry; Plant Extracts; Polycyclic Compounds; Reproducibility of Results; Schisandra | 2010 |
Schisantherin A exhibits anti-inflammatory properties by down-regulating NF-kappaB and MAPK signaling pathways in lipopolysaccharide-treated RAW 264.7 cells.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Cell Survival; Cyclooctanes; Cyclooxygenase 2; Dinoprostone; Dioxoles; Dose-Response Relationship, Drug; Extracellular Signal-Regulated MAP Kinases; I-kappa B Kinase; Inflammation Mediators; Interleukin-6; JNK Mitogen-Activated Protein Kinases; Lignans; Lipopolysaccharides; Macrophages; MAP Kinase Signaling System; Mice; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2010 |
Protective effects of dibenzocyclooctadiene lignans from Schisandra chinensis against beta-amyloid and homocysteine neurotoxicity in PC12 cells.
Topics: Amyloid beta-Peptides; Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cyclooctanes; Dioxoles; Homocysteine; Lignans; Neuroprotective Agents; PC12 Cells; Peptide Fragments; Polycyclic Compounds; Rats; Reactive Oxygen Species; Schisandra | 2011 |
Identification of novel pregnane X receptor activators from traditional Chinese medicines.
Topics: 4-Butyrolactone; Berberine; Cyclooctanes; Cytochrome P-450 CYP3A; Dioxoles; Drugs, Chinese Herbal; Genes, Reporter; Hep G2 Cells; Herb-Drug Interactions; Humans; Lignans; Magnoliopsida; Medicine, Chinese Traditional; Plants, Medicinal; Pregnane X Receptor; Receptors, Steroid; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Stilbenes | 2011 |
Simultaneous and rapid determination of main lignans in different parts of Schisandra sphenanthera by micellar electrokinetic capillary chromatography.
Topics: Chromatography, Micellar Electrokinetic Capillary; Cyclooctanes; Dioxoles; Lignans; Polycyclic Compounds | 2011 |
Preparation of high purity biphenyl cyclooctene lignans from Schisandra extract by ion exchange resin catalytic transformation combined with macroporous resin separation.
Topics: Adsorption; Analysis of Variance; Chromatography, Ion Exchange; Cyclooctanes; Dioxoles; Ethanol; Fruit; Hydrolysis; Ion Exchange Resins; Lignans; Plant Extracts; Polycyclic Compounds; Schisandra; Spectrometry, Mass, Electrospray Ionization; Temperature | 2011 |
[Influence of different processing method and mature stage on main chemical constituents of Schisandra chinensis].
Topics: Cyclooctanes; Dioxoles; Furaldehyde; Lignans; Oils, Volatile; Plant Extracts; Plants, Medicinal; Polysaccharides; Schisandra; Temperature; Time Factors | 2011 |
Anti-inflammatory effect of heme oxygenase-1 toward Porphyromonas gingivalis lipopolysaccharide in macrophages exposed to gomisins A, G, and J.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Cyclooctanes; Dioxoles; Fruit; Heme Oxygenase-1; Inflammation; Interleukin-1beta; Interleukin-6; Lignans; Lipopolysaccharides; Membrane Proteins; Mice; NF-kappa B; Plant Extracts; Polycyclic Compounds; Porphyromonas gingivalis; Schisandra; Signal Transduction; Tumor Necrosis Factor-alpha | 2011 |
Homogeneous ionic liquid microextraction of the active constituents from fruits of Schisandra chinensis and Schisandra sphenanthera.
Topics: Chromatography, High Pressure Liquid; Cyclooctanes; Dioxoles; Fruit; Imidazoles; Ionic Liquids; Lignans; Polycyclic Compounds; Schisandra | 2012 |
[Simultaneous quantitative analysis of four lignanoids in Schisandra chinensis by quantitative analysis of multi-components by single marker].
Topics: Chromatography, High Pressure Liquid; Cyclooctanes; Dioxoles; Drugs, Chinese Herbal; Fruit; Lignans; Plants, Medicinal; Polycyclic Compounds; Quality Control; Schisandra | 2012 |
Pharmacokinetic study of schisandrin, schisandrol B, schisantherin A, deoxyschisandrin, and schisandrin B in rat plasma after oral administration of Shengmaisan formula by UPLC-MS.
Topics: Administration, Oral; Animals; Chromatography, High Pressure Liquid; Cyclooctanes; Dioxoles; Drugs, Chinese Herbal; Lignans; Male; Polycyclic Compounds; Rats; Rats, Wistar; Spectrometry, Mass, Electrospray Ionization | 2013 |
Strong inhibition of deoxyschizandrin and schisantherin A toward UDP-glucuronosyltransferase (UGT) 1A3 indicating UGT inhibition-based herb–drug interaction.
Topics: Cyclooctanes; Dioxoles; Glucuronosyltransferase; Herb-Drug Interactions; Lignans; Molecular Structure; Polycyclic Compounds; Protein Isoforms | 2012 |
Development of a UFLC-MS/MS method for simultaneous determination of six lignans of Schisandra chinensis (Turcz.) Baill. in rat plasma and its application to a comparative pharmacokinetic study in normal and insomnic rats.
Topics: Animals; Chromatography, High Pressure Liquid; Cyclooctanes; Dioxoles; Drugs, Chinese Herbal; Lignans; Male; Medicine, Chinese Traditional; Polycyclic Compounds; Random Allocation; Rats; Rats, Sprague-Dawley; Schisandra; Sensitivity and Specificity; Sleep Initiation and Maintenance Disorders; Tandem Mass Spectrometry | 2013 |
Protective role of deoxyschizandrin and schisantherin A against myocardial ischemia-reperfusion injury in rats.
Topics: Animals; Apoptosis; Arrhythmias, Cardiac; Cardiotonic Agents; Caspase 3; Cyclooctanes; Cytoprotection; Dioxoles; Disease Models, Animal; Gene Expression Regulation; Hemodynamics; Hydrogen Peroxide; Lignans; Male; Malondialdehyde; Membrane Glycoproteins; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Myocytes, Cardiac; NADPH Oxidase 2; NADPH Oxidases; Polycyclic Compounds; Rats; Rats, Wistar; RNA, Messenger; Superoxide Dismutase | 2013 |
In vivo to in vitro effects of six bioactive lignans of Wuzhi tablet (Schisandra sphenanthera extract) on the CYP3A/P-glycoprotein-mediated absorption and metabolism of tacrolimus.
Topics: Absorption; Animals; ATP Binding Cassette Transporter, Subfamily B; Biological Availability; Caco-2 Cells; Cell Line, Tumor; Cyclooctanes; Cytochrome P-450 CYP3A; Dioxoles; Drugs, Chinese Herbal; Humans; Lignans; Male; Microsomes, Liver; Polycyclic Compounds; Rats; Rats, Sprague-Dawley; Tablets; Tacrolimus | 2014 |
Comparison of anti-inflammatory potential of four different dibenzocyclooctadiene lignans in microglia; action via activation of PKA and Nrf-2 signaling and inhibition of MAPK/STAT/NF-κB pathways.
Topics: Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Cyclic AMP-Dependent Protein Kinases; Cyclooctanes; Dioxoles; Lignans; Lipopolysaccharides; MAP Kinase Signaling System; Mice, Inbred ICR; Microglia; Neuroprotective Agents; NF-E2-Related Factor 2; NF-kappa B; Polycyclic Compounds; Reactive Oxygen Species; STAT Transcription Factors; Toll-Like Receptor 2 | 2014 |
[High performance preparation and structural confirmation of lignans from Schisandrae chinensis fructus by using HSCCC combined with ESI-MSn method].
Topics: Countercurrent Distribution; Cyclooctanes; Dioxoles; Drugs, Chinese Herbal; Fruit; Lignans; Molecular Structure; Plants, Medicinal; Polycyclic Compounds; Schisandra; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2014 |
Schisantherin A recovers Aβ-induced neurodegeneration with cognitive decline in mice.
Topics: Amyloid beta-Peptides; Analysis of Variance; Animals; Antioxidants; Brain; Cognition Disorders; Cyclooctanes; Dioxoles; Disease Models, Animal; Glutathione; Glutathione Peroxidase; Injections, Intraventricular; Lignans; Male; Malondialdehyde; Maze Learning; Mice; Mice, Inbred Strains; Neurodegenerative Diseases; Peptide Fragments; Superoxide Dismutase | 2014 |
Schisantherin A suppresses osteoclast formation and wear particle-induced osteolysis via modulating RANKL signaling pathways.
Topics: Animals; Bone Resorption; Cell Differentiation; Cell Survival; Cyclooctanes; Dioxoles; Disease Models, Animal; Lignans; Mice; Mice, Inbred C57BL; NF-kappa B; NFATC Transcription Factors; Osteoclasts; Osteolysis; RANK Ligand; Signal Transduction | 2014 |
Schisantherin A protects lipopolysaccharide-induced acute respiratory distress syndrome in mice through inhibiting NF-κB and MAPKs signaling pathways.
Topics: Animals; Anti-Inflammatory Agents; Cyclooctanes; Cytokines; Dioxoles; Fruit; Humans; Lignans; Lipopolysaccharides; Lung; Macrophages, Alveolar; Male; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinase Kinases; Neutrophils; NF-kappa B; Phytotherapy; Plant Extracts; Respiratory Distress Syndrome; Schisandra; Signal Transduction | 2014 |
Alleviation of severe inflammatory responses in LPS-exposed mice by Schisantherin A.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Cell Movement; Cyclooctanes; Dioxoles; Disease Models, Animal; Dose-Response Relationship, Drug; Lignans; Lipopolysaccharides; Male; Malondialdehyde; Mice; Mice, Inbred BALB C; Neutrophil Infiltration; Neutrophils; Peroxidase; Pulmonary Edema; Signal Transduction; Superoxide Dismutase; Survival Analysis | 2014 |
Hepato-protective effects of six schisandra lignans on acetaminophen-induced liver injury are partially associated with the inhibition of CYP-mediated bioactivation.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Chemical and Drug Induced Liver Injury; Cyclooctanes; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP3A; Dioxoles; Lignans; Liver; Male; Membrane Proteins; Mice, Inbred C57BL; Polycyclic Compounds; Protective Agents; Schisandra | 2015 |
Discovery of novel anti-parkinsonian effect of schisantherin A in in vitro and in vivo.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Antiparkinson Agents; Brain; Cell Line, Tumor; Cell Survival; Cyclic AMP Response Element-Binding Protein; Cyclooctanes; Dioxoles; Dopaminergic Neurons; Humans; Lignans; Male; Mice, Inbred C57BL; Neuroprotective Agents; Parkinson Disease; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Signal Transduction | 2015 |
Comparative pharmacokinetics and tissue distribution profiles of lignan components in normal and hepatic fibrosis rats after oral administration of Fuzheng Huayu recipe.
Topics: Administration, Oral; Animals; Cyclooctanes; Dioxoles; Drugs, Chinese Herbal; Kidney; Lignans; Liver; Liver Cirrhosis; Male; Polycyclic Compounds; Rats; Rats, Wistar; Tissue Distribution | 2015 |
[Determination of lignanoids in seeds of Schisandra chinensis by combinative methods of fingerprint and QAMS].
Topics: Chromatography, High Pressure Liquid; Cyclooctanes; Dioxoles; Lignans; Polycyclic Compounds; Reproducibility of Results; Schisandra; Seeds | 2014 |
Schisantherin A protects against 6-OHDA-induced dopaminergic neuron damage in zebrafish and cytotoxicity in SH-SY5Y cells through the ROS/NO and AKT/GSK3β pathways.
Topics: Animals; Antiparkinson Agents; Cell Line, Tumor; Cyclooctanes; Dioxoles; Dopaminergic Neurons; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Lignans; Neuroblastoma; Neuroprotective Agents; Nitric Oxide; Oxidative Stress; Oxidopamine; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Schisandra; Signal Transduction; Zebrafish | 2015 |
Inhibition of UDP-Glucuronosyltransferases (UGTs) Activity by constituents of Schisandra chinensis.
Topics: Animals; Cyclooctanes; Dioxoles; Drugs, Chinese Herbal; Glucuronosyltransferase; Herb-Drug Interactions; Lignans; Plant Extracts; Polycyclic Compounds; Rats; Schisandra; Structure-Activity Relationship | 2015 |
Drug-drug interation prediction between ketoconazole and anti-liver cancer drug Gomisin G.
Topics: Antineoplastic Agents; Cyclooctanes; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dioxoles; Drug Interactions; Humans; Ketoconazole; Lignans; Liver; Liver Neoplasms; Molecular Docking Simulation; Plant Extracts; Schisandra | 2015 |
Schisantherin A suppresses interleukin-1β-induced inflammation in human chondrocytes via inhibition of NF-κB and MAPKs activation.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cell Survival; Chondrocytes; Cyclooctanes; Cyclooxygenase 2; Dinoprostone; Dioxoles; Enzyme Activation; Humans; Interleukin-1beta; Lignans; Matrix Metalloproteinases; Middle Aged; Mitogen-Activated Protein Kinases; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Osteoarthritis; Tumor Necrosis Factor-alpha | 2016 |
Oral Delivery of a Nanocrystal Formulation of Schisantherin A with Improved Bioavailability and Brain Delivery for the Treatment of Parkinson's Disease.
Topics: Administration, Oral; Animals; Brain; Cyclooctanes; Dioxoles; Disease Models, Animal; Drug Compounding; Lignans; Male; Nanoparticles; Parkinson Disease; Rats, Sprague-Dawley; Zebrafish | 2016 |
Small-Sized mPEG-PLGA Nanoparticles of Schisantherin A with Sustained Release for Enhanced Brain Uptake and Anti-Parkinsonian Activity.
Topics: Animals; Brain; Cyclooctanes; Delayed-Action Preparations; Dioxoles; Dogs; Drug Carriers; Lignans; Nanoparticles; Particle Size; Polyesters; Polyethylene Glycols; Rats | 2017 |
Inhibition of human CYP3A4 and CYP3A5 enzymes by gomisin C and gomisin G, two lignan analogs derived from Schisandra chinensis.
Topics: Cyclooctanes; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Dioxoles; Herb-Drug Interactions; Humans; Hydroxylation; Lignans; Midazolam; Molecular Structure; Nifedipine; Oxidation-Reduction; Schisandra; Testosterone | 2017 |
Schisantherin A protects against liver ischemia-reperfusion injury via inhibition of mitogen-activated protein kinase pathway.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Cyclooctanes; Dioxoles; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Humans; Lignans; Liver; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Reperfusion Injury; Schisandraceae; Signal Transduction | 2017 |
Schisantherin A attenuates ischemia/reperfusion-induced neuronal injury in rats via regulation of TLR4 and C5aR1 signaling pathways.
Topics: Animals; Apoptosis; Brain Ischemia; Cell Survival; Cerebral Cortex; Cyclooctanes; Dioxoles; Inflammation; Lignans; Necrosis; Neurons; Neuroprotective Agents; Oxidative Stress; Parietal Lobe; Primary Cell Culture; Rats, Sprague-Dawley; Receptor, Anaphylatoxin C5a; Reperfusion Injury; Signal Transduction; Toll-Like Receptor 4 | 2017 |
[Effect of schisantherin A inhibit liver sinusoid endothelial cell function and action against liver fibrosis relating to angiogenesis].
Topics: Angiogenesis Inhibitors; Animals; Capillaries; Cell Movement; Cell Proliferation; Cyclooctanes; Dioxoles; Endothelial Cells; Humans; Lignans; Liver; Liver Cirrhosis; Neovascularization, Pathologic; Rats; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor A; Zebrafish | 2016 |
Prediction of Drug-Drug Interaction between Tacrolimus and Principal Ingredients of Wuzhi Capsule in Chinese Healthy Volunteers Using Physiologically-Based Pharmacokinetic Modelling.
Topics: Area Under Curve; Biotransformation; China; Computational Biology; Computer Simulation; Cyclooctanes; Cytochrome P-450 CYP3A Inhibitors; Dioxoles; Dose-Response Relationship, Drug; Drug Interactions; Drugs, Chinese Herbal; Expert Systems; Female; Humans; Immunosuppressive Agents; Lignans; Male; Models, Biological; Polycyclic Compounds; Protective Agents; Software; Tacrolimus | 2018 |
Schisantherin A alleviated alcohol-induced liver injury by the regulation of alcohol metabolism and NF-kB pathway.
Topics: Alanine Transaminase; Alcohol Dehydrogenase; Aldehyde Oxidoreductases; Animals; Aspartate Aminotransferases; Cyclooctanes; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2E1; Dioxoles; Disease Models, Animal; Dose-Response Relationship, Drug; Ethanol; Lignans; Liver; Liver Diseases, Alcoholic; Male; Mice, Inbred C57BL; NF-kappa B; Oxidative Stress; Phytotherapy; Schisandra; Signal Transduction | 2018 |
Schisantherin A Improves Learning and Memory of Mice with D-Galactose-Induced Learning and Memory Impairment Through Its Antioxidation and Regulation of p19/p53/p21/Cyclin D1/CDK4/RB Gene Expressions.
Topics: Animals; Cyclin D1; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase Inhibitor p19; Cyclooctanes; Dioxoles; Drugs, Chinese Herbal; Galactose; Gene Expression; Hippocampus; Humans; Learning Disabilities; Lignans; Male; Memory; Memory Disorders; Mice; Mice, Inbred ICR; Retinoblastoma Protein; rho GTP-Binding Proteins; Schisandra; Tumor Suppressor Protein p53 | 2018 |
[Determination of hepatic and small intestinal distribution of lignans of Wuzhi tablet in rats by liquid chromatography tandem mass spectrometry method].
Topics: Animals; Chromatography, Liquid; Cyclooctanes; Dioxoles; Drugs, Chinese Herbal; Intestine, Small; Lignans; Liver; Male; Polycyclic Compounds; Rats; Rats, Sprague-Dawley; Schisandra; Tablets; Tandem Mass Spectrometry | 2016 |
[Rapid identification of the different constituents in Fructus Schisandrae Chinensis before and after processing by UHPLC-QTOF/MS~E combining with metabonomics].
Topics: Chromatography, High Pressure Liquid; Cyclooctanes; Dioxoles; Drugs, Chinese Herbal; Fruit; Lignans; Metabolomics; Polycyclic Compounds; Schisandra | 2016 |
[Analysis of lignans and their metabolites derived from Schisandra chinensis and vinegar Schisandra chinensis in rats’ plasma, bile, urine and faeces based on UHPLC-QTOF/MS].
Topics: Acetic Acid; Animals; Bile; Chromatography, High Pressure Liquid; Cyclooctanes; Dioxoles; Drugs, Chinese Herbal; Feces; Lignans; Liver Diseases, Alcoholic; Plasma; Polycyclic Compounds; Rats; Schisandra; Urine | 2016 |
Schisantherin A Attenuates Neuroinflammation in Activated Microglia: Role of Nrf2 Activation Through ERK Phosphorylation.
Topics: Animals; Cell Line, Transformed; Cyclooctanes; Dioxoles; Inflammation; Lignans; MAP Kinase Signaling System; Mice; Microglia; NF-E2-Related Factor 2; Phosphorylation | 2018 |
Chemical constituents isolated from stems of
Topics: Animals; Cyclooctanes; Dioxoles; Feeding Behavior; Lignans; Plant Stems; Polycyclic Compounds; Schisandra; Sesquiterpenes; Structure-Activity Relationship; Tribolium; Triterpenes | 2020 |
Systematically identifying the hepatoprotective ingredients of schisandra lignan extract from pharmacokinetic and pharmacodynamic perspectives.
Topics: Animals; Chemical and Drug Induced Liver Injury; Chromatography, Liquid; Cyclooctanes; Dioxoles; Drug Evaluation, Preclinical; Lignans; Liver; Male; Mass Spectrometry; Mice, Inbred BALB C; Plant Extracts; Protective Agents; Rats, Sprague-Dawley; Schisandra | 2019 |
The Pharmacokinetic Prediction of Cyclosporin A after Coadministration with Wuzhi Capsule.
Topics: Adult; Cyclooctanes; Cyclosporine; Dioxoles; Drugs, Chinese Herbal; Herb-Drug Interactions; Humans; Immunosuppressive Agents; Lignans; Male; Polycyclic Compounds | 2019 |
Schisantherin A induces cell apoptosis through ROS/JNK signaling pathway in human gastric cancer cells.
Topics: Apoptosis; Caspases; Cell Line, Tumor; Cell Movement; Cyclooctanes; Dioxoles; G2 Phase Cell Cycle Checkpoints; Humans; Lignans; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Molecular Structure; Phosphorylation; Plant Extracts; Reactive Oxygen Species; Schisandra; Stomach Neoplasms | 2020 |
Screening and Identification of the Main Metabolites of Schisantherin a In Vivo and In Vitro by Using UHPLC-Q-TOF-MS/MS.
Topics: Animals; Chromatography, High Pressure Liquid; Cyclooctanes; Dioxoles; Drug Evaluation, Preclinical; Ions; Lignans; Male; Metabolic Networks and Pathways; Metabolome; Metabolomics; Oxidation-Reduction; Rats, Sprague-Dawley; Tandem Mass Spectrometry | 2020 |
Schisantherin A causes endothelium-dependent and -independent vasorelaxation in isolated rat thoracic aorta.
Topics: Animals; Aorta, Thoracic; Blotting, Western; Calcium; Cyclooctanes; Dioxoles; Dose-Response Relationship, Drug; Endothelium, Vascular; Lignans; Male; Potassium Channel Blockers; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Vasodilation; Vasodilator Agents | 2020 |
Effects of 27 natural products on drug metabolism genes in channel catfish (
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Products; Biotransformation; Cell Line; Cyclooctanes; Cytochrome P-450 Enzyme System; Dioxoles; Ictaluridae; Lignans; Polycyclic Compounds; Pregnane X Receptor | 2020 |
Study on the potential effective ingredients of Xiaosheng prescription for dry eye disease.
Topics: Animals; Cyclooctanes; Dioxoles; Drugs, Chinese Herbal; Epithelium, Corneal; Female; Humans; Lignans; Mice; Plant Extracts; Polycyclic Compounds | 2020 |
Schisantherin A attenuates sepsis-induced acute kidney injury by suppressing inflammation via regulating the NRF2 pathway.
Topics: Acute Kidney Injury; Animals; Anti-Inflammatory Agents; Cell Line; Cyclooctanes; Dioxoles; Inflammation; Kidney; Lignans; Male; Mice; NF-E2-Related Factor 2; Rats; Sepsis; Signal Transduction | 2020 |
Schisantherin A ameliorates liver fibrosis through TGF-β1mediated activation of TAK1/MAPK and NF-κB pathways in vitro and in vivo.
Topics: Animals; Cell Line; Cyclooctanes; Cytokines; Dioxoles; Hepatic Stellate Cells; Lignans; Liver Cirrhosis; Male; MAP Kinase Kinase Kinases; Mice, Inbred ICR; Mitogen-Activated Protein Kinases; NF-kappa B; Rats; Signal Transduction; Thioacetamide; Transforming Growth Factor beta1 | 2021 |
Schisantherin A alleviates non-alcoholic fatty liver disease by restoring intestinal barrier function.
Topics: Animals; Anti-Bacterial Agents; Cyclooctanes; Dioxoles; Inflammation; Lignans; Lipopolysaccharides; Liver; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; RNA, Ribosomal, 16S; Toll-Like Receptor 4 | 2022 |